Skip to main content

Table 3.

Categories of Response Based on Reliable Change to PAP Therapy Stratified by Hours of Usage

Instrument Worsening No Change Improvement Symptom Remission
SDA
 Overall (N = 103)a 3 (2.9) 69 (67.0) 7 (6.8) 24 (23.3)
 Average hourly PAP use
 0.0-1.9 (n = 25) 2 (8.0) 17 (68.0) 1 (4.0) 5 (20.0)
 2.0-3.9 (n = 28) 0 (0) 18 (64.3) 4 (14.3) 6 (21.4)
 4.0-5.9 (n = 28) 1 (3.6) 22 (78.6) 1 (3.6) 4 (14.3)
 ≥ 6.0 (n = 22) 0 (0) 12 (54.6) 1 (4.6) 9 (40.9)
SRI
 Overall (N = 103)a 11 (10.7) 53 (51.5) 7 (6.8) 32 (31.1)
 Average hourly PAP use
 < 2.0 (n = 25)a 5 (20.0) 14 (56.0) 1 (4.0) 5 (20.0)
 2.0-3.9 (n = 28) 2 (7.1) 14 (50.0) 3 (10.7) 9 (32.1)
 4.0-5.9 (n = 28)a 2 (7.1) 15 (53.6) 2 (7.1) 9 (32.1)
 ≥ 6.0 (n = 22) 2 (9.1) 10 (45.5) 1 (4.6) 9 (40.9)
ESS
 Overall (N = 103) 2 (1.9) 90 (87.4) 5 (4.9) 6 (5.8)
 Average hourly PAP use
 < 2.0 (n = 25) 0 (0) 22 (88.0) 2 (8.0) 1 (4.0)
 2.0-3.9 (n = 28) 1 (3.6) 23 (82.1) 1 (3.6) 3 (10.7)
 4.0-5.9 (n = 28) 0 (0) 27 (96.4) 1 (3.6) 0 (0)
 ≥ 6.0 (n = 22) 1 (4.6) 18 (81.8) 1 (4.6) 2 (9.1)

Values are No. (%). See Table 1 legend for expansion of abbreviations.

a

P < .05 for difference from ESS proportion by χ2 test. No significant differences were found between SDA and SRI.